| __timestamp | CRISPR Therapeutics AG | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1513000 | 11768000 |
| Thursday, January 1, 2015 | 12573000 | 15152000 |
| Friday, January 1, 2016 | 42238000 | 19828000 |
| Sunday, January 1, 2017 | 69800000 | 25573000 |
| Monday, January 1, 2018 | 113773000 | 23634000 |
| Tuesday, January 1, 2019 | 179362000 | 38845000 |
| Wednesday, January 1, 2020 | 266946000 | 50523000 |
| Friday, January 1, 2021 | 438633000 | 75463000 |
| Saturday, January 1, 2022 | 461645000 | 105767000 |
| Sunday, January 1, 2023 | 387332000 | 167512000 |
| Monday, January 1, 2024 | 320653000 |
Unleashing insights
In the rapidly evolving world of biotechnology, research and development (R&D) are the lifeblood of innovation. Over the past decade, CRISPR Therapeutics AG and Xenon Pharmaceuticals Inc. have been at the forefront of this revolution, channeling significant resources into groundbreaking research.
From 2014 to 2023, CRISPR Therapeutics AG has seen its R&D expenses skyrocket by over 25,000%, reflecting its commitment to advancing gene-editing technologies. In contrast, Xenon Pharmaceuticals Inc. has increased its R&D spending by approximately 1,300%, focusing on neurological disorders.
By 2023, CRISPR Therapeutics AG's R&D expenses reached a peak of nearly 39% higher than its 2014 levels, while Xenon Pharmaceuticals Inc. saw a 42% increase from the previous year. These investments underscore the relentless pursuit of innovation in the biotech sector, promising a future of transformative therapies.
Gilead Sciences, Inc. or Xenon Pharmaceuticals Inc.: Who Invests More in Innovation?
R&D Insights: How Biogen Inc. and CRISPR Therapeutics AG Allocate Funds
Research and Development Investment: Incyte Corporation vs CRISPR Therapeutics AG
Research and Development: Comparing Key Metrics for Summit Therapeutics Inc. and Xenon Pharmaceuticals Inc.
R&D Insights: How Lantheus Holdings, Inc. and CRISPR Therapeutics AG Allocate Funds
R&D Insights: How Lantheus Holdings, Inc. and Xenon Pharmaceuticals Inc. Allocate Funds
Research and Development Expenses Breakdown: CRISPR Therapeutics AG vs Arrowhead Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? CRISPR Therapeutics AG or Xenon Pharmaceuticals Inc.
Comparing Innovation Spending: CRISPR Therapeutics AG and Ligand Pharmaceuticals Incorporated
R&D Spending Showdown: CRISPR Therapeutics AG vs Dynavax Technologies Corporation
Xenon Pharmaceuticals Inc. or HUTCHMED (China) Limited: Who Invests More in Innovation?
R&D Spending Showdown: Xenon Pharmaceuticals Inc. vs MannKind Corporation